Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Daily News

比伐卢定标签更新，警告 STEMI 患者 PCI 后的急性支架血栓事件，建议持续输液

Shelley Wood

April 18, 2016

News Daily News

Label Update for Bivalirudin Warns of Acute Stent Thrombosis With PCI for STEMI, Recommends Continued Infusion

Shelley Wood

April 18, 2016

News Daily News

La Actualización del Prospecto de Bivalirudina Advierte del Riesgo de Trombosis Aguda de Stent con PCI para el Manejo de STEMI y Recomienda la Infusión Continuada

Shelley Wood

April 18, 2016

News Daily News

Los Dispositivos Cardiovasculares son la Clase Más Amplia de Dispositivo Retirados por la FDA desde 2005

Yael L. Maxwell

April 03, 2014

News Daily News

Cardiovascular Devices Make Up Largest Class of FDA Device Recalls Since 2005

Yael L. Maxwell

April 03, 2014

News Daily News

Study Suggests FFR Diagnostic ‘Gray Zone’ Complicates Clinical Decision Making

L.A. McKeown

March 25, 2013

News Daily News

Estudio sugiere que ‘zona gris’ en el diagnóstico de la FFR complica la toma de decisiones clínicas

L.A. McKeown

March 25, 2013

News Daily News

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Jason Kahn

July 21, 2011

News Daily News

Mental Outlook Linked to Long-term Survival After CHD Hospitalization

Caitlin E. Cox

March 01, 2011

News Daily News

Report on Device Recalls Criticizes Current FDA Approval Process

L.A. McKeown

February 14, 2011

Advertisement

比伐卢定标签更新，警告 STEMI 患者 PCI 后的急性支架血栓事件，建议持续输液

Label Update for Bivalirudin Warns of Acute Stent Thrombosis With PCI for STEMI, Recommends Continued Infusion

La Actualización del Prospecto de Bivalirudina Advierte del Riesgo de Trombosis Aguda de Stent con PCI para el Manejo de STEMI y Recomienda la Infusión Continuada

Los Dispositivos Cardiovasculares son la Clase Más Amplia de Dispositivo Retirados por la FDA desde 2005

Cardiovascular Devices Make Up Largest Class of FDA Device Recalls Since 2005

Study Suggests FFR Diagnostic ‘Gray Zone’ Complicates Clinical Decision Making

Estudio sugiere que ‘zona gris’ en el diagnóstico de la FFR complica la toma de decisiones clínicas

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Mental Outlook Linked to Long-term Survival After CHD Hospitalization

Report on Device Recalls Criticizes Current FDA Approval Process

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content